PIK3CB is involved in metastasis through the regulation of cell adhesion to collagen I in pancreatic cancer
- PMID: 34603784
- PMCID: PMC8463925
- DOI: 10.1016/j.jare.2021.02.002
PIK3CB is involved in metastasis through the regulation of cell adhesion to collagen I in pancreatic cancer
Abstract
Introduction: Pancreatic adenocarcinoma (PAAD) is an aggressive malignancy, with a major mortality resulting from the rapid progression of metastasis. Unfortunately, no effective treatment strategy has been developed for PAAD metastasis to date. Thus, unraveling the mechanisms involved in PAAD metastatic phenotype may facilitate the treatment for PAAD patients.
Objectives: PIK3CB is an oncogene implicated in cancer development and progression but less is known about whether PIK3CB participates in PAAD metastasis. Therefore, the objective of this study is to explore the mechanism(s) of PIK3CB in PAAD metastasis.
Methods: In our study, we examined the PIK3CB expression pattern using bioinformatic analysis and clinical material derived from patients with PAAD. Subsequently, a series of biochemical experiments were conducted to investigate the role of PIK3CB as potential mechanism(s) underlying PAAD metastasis in vivo using nude mice and in vitro using cell lines.
Results: We observed that PIK3CB was involved in PAAD progression. Notably, we identified that PIK3CB was involved in PAAD metastasis. Downregulation of PIK3CB significantly reduced PAAD metastatic potential in vivo. Furthermore, a series of bioinformatic analyses showed that PIK3CB was involved in cell adhesion in PAAD. Notably, PIK3CB depletion inhibited invasion potential specifically via suppressing cell adhesion to collagen I in PAAD cells.
Conclusion: Collectively, our findings indicate that PIK3CB is involved in PAAD metastasis through cell-matrix adhesion. We proposed that PIK3CB is a potential therapeutic target for PAAD therapy.
Keywords: Adhesion; Collagen I; Metastasis; PIK3CB; Pancreatic cancer.
© 2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures








Similar articles
-
N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression.Gut. 2020 Dec;69(12):2180-2192. doi: 10.1136/gutjnl-2019-320179. Epub 2020 Apr 20. Gut. 2020. PMID: 32312789
-
PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis.Front Immunol. 2022 Jan 27;13:805311. doi: 10.3389/fimmu.2022.805311. eCollection 2022. Front Immunol. 2022. PMID: 35154122 Free PMC article.
-
ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.Int J Biol Sci. 2021 Apr 24;17(7):1808-1820. doi: 10.7150/ijbs.55919. eCollection 2021. Int J Biol Sci. 2021. PMID: 33994864 Free PMC article.
-
GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets.Br J Pharmacol. 2020 Jun;177(11):2434-2455. doi: 10.1111/bph.15028. Epub 2020 Apr 12. Br J Pharmacol. 2020. PMID: 32060895 Free PMC article. Review.
-
Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.Biosci Rep. 2022 Feb 25;42(2):BSR20212523. doi: 10.1042/BSR20212523. Biosci Rep. 2022. PMID: 35083488 Free PMC article. Review.
Cited by
-
A novel natural killer cell-related signatures to predict prognosis and chemotherapy response of pancreatic cancer patients.Front Genet. 2023 Mar 23;14:1100020. doi: 10.3389/fgene.2023.1100020. eCollection 2023. Front Genet. 2023. PMID: 37035749 Free PMC article.
-
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.Front Oncol. 2022 Jul 22;12:927640. doi: 10.3389/fonc.2022.927640. eCollection 2022. Front Oncol. 2022. PMID: 35936737 Free PMC article. Review.
-
Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer.Cells. 2022 Apr 19;11(9):1382. doi: 10.3390/cells11091382. Cells. 2022. PMID: 35563688 Free PMC article.
-
SP1 Mediated PIK3CB Upregulation Promotes Gastric Carcinogenesis.J Cancer. 2024 Jan 20;15(5):1355-1365. doi: 10.7150/jca.83812. eCollection 2024. J Cancer. 2024. PMID: 38356702 Free PMC article.
-
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma.Mol Cancer. 2023 Jul 24;22(1):118. doi: 10.1186/s12943-023-01813-y. Mol Cancer. 2023. PMID: 37488598 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases